Platelets in chronic liver disease, from bench to bedside

被引:53
|
作者
Ramadori, Pierluigi [1 ]
Klag, Thomas [2 ]
Malek, Nisar Peter [2 ]
Heikenwalder, Mathias [1 ]
机构
[1] German Canc Res Ctr Heidelberg DKFZ, Div Chron Inflammat & Canc, Neuenheimer Feld 280, D-69120 Heidelberg, Germany
[2] Univ Tubingen, Dept Internal Med 1, Muller Str 10, D-72076 Tubingen, Germany
关键词
Platelets; cirrhosis; HCC; cancer; immune system; immunology; NASH; NAFLD; LOW-DOSE ASPIRIN; HEPATOCELLULAR-CARCINOMA; GROWTH-FACTOR; PARTIAL-HEPATECTOMY; IMPROVES SURVIVAL; HCV INFECTION; KUPFFER CELLS; DRUG-THERAPY; MOUSE MODEL; LIFE-SPAN;
D O I
10.1016/j.jhepr.2019.10.001
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In the last decade, numerous studies revealed physiologic and pathophysiologic roles of platelets beyond haemostasis, a process to prevent and stop bleeding. These include the activation of the immune system and the promotion of inflammation, infection and cancer. Hence, the emerging view on the role of platelets has shifted - platelets are nowseen as alert "sentinels" of the immune compartment, rather than passive bystanders. Herein, we review well-established and newly discovered features of platelets that define their natural role in maintaining blood haemostasis, but also their functional relationship with other cells of the immune system. We focus on recent studies underlining functional involvement of platelets in chronic liver diseases and cancer, as well as the effects of anti-platelet therapy in these contexts. Finally, we illustrate the potential of platelets as possible diagnostic and therapeutic tools in liver disease based on recently developed methodologies. (c) 2019 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:448 / 459
页数:12
相关论文
共 50 条
  • [41] Targeting Macrophages in Cancer: From Bench to Bedside
    Poh, Ashleigh R.
    Ernst, Matthias
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [42] Pseudoachondroplasia/COMP - translating from the bench to the bedside
    Posey, Karen LaShea
    Alcorn, Joseph L.
    Hecht, Jacqueline T.
    MATRIX BIOLOGY, 2014, 37 : 167 - 173
  • [43] miR-34: from bench to bedside
    Agostini, Massimiliano
    Knight, Richard A.
    ONCOTARGET, 2014, 5 (04) : 872 - 881
  • [44] Pathophysiology of septic shock: From bench to bedside
    McConnell, Kevin W.
    Coopersmith, Craig M.
    PRESSE MEDICALE, 2016, 45 (04): : E93 - E98
  • [45] Resveratrol in Cancer Patients: From Bench to Bedside
    Berretta, Massimiliano
    Bignucolo, Alessia
    Di Francia, Raffaele
    Comello, Francesco
    Facchini, Gaetano
    Ceccarelli, Manuela
    Iaffaioli, Rosario Vincenzo
    Quagliariello, Vincenzo
    Maurea, Nicola
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)
  • [46] The role of collagen in cancer: from bench to bedside
    Xu, Shuaishuai
    Xu, Huaxiang
    Wang, Wenquan
    Li, Shuo
    Li, Hao
    Li, Tianjiao
    Zhang, Wuhu
    Yu, Xianjun
    Liu, Liang
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (01)
  • [47] The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer
    Gibert-Ramos, Albert
    Sanfeliu-Redondo, David
    Aristu-Zabalza, Peio
    Martinez-Alcocer, Ana
    Gracia-Sancho, Jordi
    Guixe-Muntet, Sergi
    Fernandez-Iglesias, Anabel
    CANCERS, 2021, 13 (22)
  • [48] Regulatory T cells: From bench to bedside
    Jiang, Shuiping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2009, 9 (05) : 515 - 517
  • [49] Dendritic cells from bench to bedside and back
    Adema, G. J.
    IMMUNOLOGY LETTERS, 2009, 122 (02) : 128 - 130
  • [50] Innate-like T lymphocytes in chronic liver disease
    Papanastasatou, Maria
    Verykokakis, Mihalis
    FRONTIERS IN IMMUNOLOGY, 2023, 14